| 0 |
DYSANIA |
1 |
0.0130 |
| 1 |
SACCADIC EYE MOVEMENT |
1 |
0.0060 |
| 2 |
LIGAMENT OPERATION |
1 |
0.0029 |
| 3 |
VAGINAL ULCERATION |
1 |
0.0024 |
| 4 |
OPHTHALMIC MIGRAINE |
1 |
0.0014 |
| 5 |
NARCOLEPSY |
2 |
0.0011 |
| 6 |
PRODUCT BLISTER PACKAGING ISSUE |
1 |
0.0010 |
| 7 |
POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME |
1 |
0.0007 |
| 8 |
INTERMENSTRUAL BLEEDING |
4 |
0.0007 |
| 9 |
LABELLED DRUG-DRUG INTERACTION ISSUE |
1 |
0.0007 |
| 10 |
PHARYNGEAL PARAESTHESIA |
1 |
0.0006 |
| 11 |
OLIGOMENORRHOEA |
1 |
0.0005 |
| 12 |
LONG QT SYNDROME |
1 |
0.0004 |
| 13 |
METRORRHAGIA |
7 |
0.0004 |
| 14 |
EAR PRURITUS |
1 |
0.0003 |
| 15 |
CHRONIC SINUSITIS |
1 |
0.0003 |
| 16 |
EPIGASTRIC DISCOMFORT |
1 |
0.0003 |
| 17 |
HEAVY MENSTRUAL BLEEDING |
2 |
0.0002 |
| 18 |
HIDRADENITIS |
2 |
0.0002 |
| 19 |
FOOT OPERATION |
1 |
0.0002 |
| 20 |
PIGMENTATION DISORDER |
1 |
0.0002 |
| 21 |
INJECTION SITE IRRITATION |
2 |
0.0002 |
| 22 |
DYSMENORRHOEA |
2 |
0.0002 |
| 23 |
MAJOR DEPRESSION |
1 |
0.0001 |
| 24 |
ARTHROPOD BITE |
1 |
0.0001 |
| 25 |
POST PROCEDURAL INFECTION |
1 |
0.0001 |
| 26 |
VAGINAL DISCHARGE |
1 |
0.0001 |
| 27 |
WEIGHT FLUCTUATION |
1 |
0.0001 |
| 28 |
PRODUCT ODOUR ABNORMAL |
1 |
0.0001 |
| 29 |
POOR QUALITY PRODUCT ADMINISTERED |
1 |
0.0001 |
| 30 |
DECREASED ACTIVITY |
1 |
0.0001 |
| 31 |
MOOD ALTERED |
2 |
0.0001 |
| 32 |
IMPAIRED QUALITY OF LIFE |
1 |
0.0001 |
| 33 |
PARAESTHESIA ORAL |
1 |
0.0001 |
| 34 |
VAGINAL HAEMORRHAGE |
3 |
0.0001 |
| 35 |
ANOSMIA |
1 |
0.0001 |
| 36 |
DRUG EFFECT LESS THAN EXPECTED |
1 |
0.0001 |
| 37 |
INSURANCE ISSUE |
1 |
0.0001 |
| 38 |
BRAIN FOG |
1 |
0.0001 |
| 39 |
PRODUCT USE COMPLAINT |
1 |
0.0001 |
| 40 |
GENERALISED TONIC-CLONIC SEIZURE |
1 |
0.0001 |
| 41 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
1 |
0.0001 |
| 42 |
AMENORRHOEA |
1 |
0.0001 |
| 43 |
DERMATITIS ATOPIC |
3 |
0.0001 |
| 44 |
HEAD DISCOMFORT |
1 |
0.0001 |
| 45 |
ORAL HERPES |
1 |
0.0001 |
| 46 |
MENORRHAGIA |
1 |
0.0001 |
| 47 |
PRODUCT ADMINISTRATION ERROR |
1 |
0.0000 |
| 48 |
INJECTION SITE WARMTH |
1 |
0.0000 |
| 49 |
CLOSTRIDIUM DIFFICILE INFECTION |
1 |
0.0000 |
| 50 |
THERAPEUTIC RESPONSE UNEXPECTED |
2 |
0.0000 |
| 51 |
HYPOPHAGIA |
1 |
0.0000 |
| 52 |
THROAT TIGHTNESS |
1 |
0.0000 |
| 53 |
INTENTIONAL DOSE OMISSION |
1 |
0.0000 |
| 54 |
INJECTION SITE RASH |
1 |
0.0000 |
| 55 |
CHOLELITHIASIS |
1 |
0.0000 |
| 56 |
FUNGAL INFECTION |
1 |
0.0000 |
| 57 |
INJECTION SITE PRURITUS |
2 |
0.0000 |
| 58 |
EYE PRURITUS |
1 |
0.0000 |
| 59 |
SINUSITIS |
3 |
0.0000 |
| 60 |
HEART RATE DECREASED |
1 |
0.0000 |
| 61 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
1 |
0.0000 |
| 62 |
FLUSHING |
2 |
0.0000 |
| 63 |
FLUID RETENTION |
1 |
0.0000 |
| 64 |
DISTURBANCE IN ATTENTION |
1 |
0.0000 |
| 65 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 66 |
EYE IRRITATION |
1 |
0.0000 |
| 67 |
WHEEZING |
1 |
0.0000 |
| 68 |
THERAPEUTIC RESPONSE DECREASED |
1 |
0.0000 |
| 69 |
STOMATITIS |
1 |
0.0000 |
| 70 |
VERTIGO |
1 |
0.0000 |
| 71 |
DISCOMFORT |
1 |
0.0000 |
| 72 |
MUSCLE SPASMS |
3 |
0.0000 |
| 73 |
PRODUCT DOSE OMISSION |
1 |
0.0000 |
| 74 |
INJECTION SITE REACTION |
1 |
0.0000 |
| 75 |
SLEEP DISORDER |
1 |
0.0000 |
| 76 |
THERAPY INTERRUPTED |
1 |
0.0000 |
| 77 |
SKIN BURNING SENSATION |
1 |
0.0000 |
| 78 |
PRODUCT DOSE OMISSION ISSUE |
4 |
0.0000 |
| 79 |
BRONCHITIS |
1 |
0.0000 |
| 80 |
DYSGEUSIA |
1 |
0.0000 |
| 81 |
ACNE |
1 |
0.0000 |
| 82 |
INJECTION SITE SWELLING |
1 |
0.0000 |
| 83 |
INJECTION SITE PAIN |
4 |
0.0000 |
| 84 |
URTICARIA |
2 |
0.0000 |
| 85 |
PRODUCT STORAGE ERROR |
1 |
0.0000 |
| 86 |
INTENTIONAL PRODUCT USE ISSUE |
1 |
0.0000 |
| 87 |
GASTROINTESTINAL DISORDER |
1 |
0.0000 |
| 88 |
SUICIDAL IDEATION |
1 |
0.0000 |
| 89 |
CONTUSION |
1 |
0.0000 |
| 90 |
CHEST DISCOMFORT |
1 |
0.0000 |
| 91 |
ABDOMINAL PAIN UPPER |
2 |
0.0000 |
| 92 |
ASTHMA |
1 |
0.0000 |
| 93 |
DEPRESSION |
2 |
0.0000 |
| 94 |
SEIZURE |
1 |
0.0000 |
| 95 |
BACK PAIN |
2 |
0.0000 |
| 96 |
EMOTIONAL DISTRESS |
1 |
0.0000 |
| 97 |
VISUAL IMPAIRMENT |
1 |
0.0000 |
| 98 |
INJECTION SITE ERYTHEMA |
1 |
0.0000 |
| 99 |
DIZZINESS |
4 |
0.0000 |
| 100 |
OFF LABEL USE |
7 |
0.0000 |
| 101 |
PRURITUS |
3 |
0.0000 |
| 102 |
LOSS OF CONSCIOUSNESS |
1 |
0.0000 |
| 103 |
NAUSEA |
6 |
0.0000 |
| 104 |
DRY SKIN |
1 |
0.0000 |
| 105 |
PRODUCT QUALITY ISSUE |
1 |
0.0000 |
| 106 |
VISION BLURRED |
1 |
0.0000 |
| 107 |
ANXIETY |
2 |
0.0000 |
| 108 |
PAIN |
4 |
0.0000 |
| 109 |
DRUG INTERACTION |
1 |
0.0000 |
| 110 |
DRUG DOSE OMISSION |
1 |
0.0000 |
| 111 |
TREMOR |
1 |
0.0000 |
| 112 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1 |
0.0000 |
| 113 |
NO ADVERSE EVENT |
1 |
0.0000 |
| 114 |
NASOPHARYNGITIS |
1 |
0.0000 |
| 115 |
ALOPECIA |
1 |
0.0000 |
| 116 |
ERYTHEMA |
1 |
0.0000 |
| 117 |
CONSTIPATION |
1 |
0.0000 |
| 118 |
MALAISE |
2 |
0.0000 |
| 119 |
WEIGHT INCREASED |
1 |
0.0000 |
| 120 |
VOMITING |
2 |
0.0000 |
| 121 |
FEELING ABNORMAL |
1 |
0.0000 |
| 122 |
WEIGHT DECREASED |
1 |
0.0000 |
| 123 |
CONDITION AGGRAVATED |
1 |
0.0000 |
| 124 |
DIARRHOEA |
2 |
0.0000 |
| 125 |
PNEUMONIA |
1 |
0.0000 |
| 126 |
FALL |
1 |
0.0000 |
| 127 |
ASTHENIA |
1 |
0.0000 |
| 128 |
FATIGUE |
2 |
0.0000 |
| 129 |
RASH |
1 |
0.0000 |
| 130 |
DRUG INEFFECTIVE |
3 |
0.0000 |
| 131 |
HEADACHE |
1 |
0.0000 |